11 - Mutation Detection 1 Flashcards

1
Q

Steps of PCR

A
  • Denaturing (separating double stranded DNA at 95ºC)
  • Annealing (facilitating primer attachment to template strands at 55-65ºC)
  • Elongation (synthesis of new DNA strands from primers by Taq polymerase at 72ºC )
  • Repeat
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

Real time PCR allelic discrimination

A
  • Fluorescent molecule used to indicate replication of sequence during PCR
  • Uses Taqman technology
  • Different colours distinguish different variants
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

Which strands do forward and reverse primers bind to

A

Forward: Template strand
Reverse: Coding strand

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

Taqman technology

A
  • Probe has a flourophore and a quencher bound
  • Fluorescence only occurs when they are no longer in proximity
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

Steps of Real time PCR (Allelic discrimination)

A
  • Probe binds to target sequencing containing SNP
  • During PCR, polymerase removes the fluorophore
  • Fluorescent signal indicates SNP sequence
  • If variant wasn’t present, probe would never bind and therefore wouldn’t fluoresce
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

Advantages of real time PCR (Allelic discrimination)

A
  • Discriminate between genotypes
  • Multiple samples analysed simultaneously
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

Melt curve analysis

A
  • Changes in sequence lead to changes in Tm.
  • Mutant sequences have different Tm (become ss at different temp to wild type)
  • when dsDNA denatures to ssDNA, no more fluorescence (dye binds to dsDNA only)
  • measured at 50/50 ratio
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

Heteroduplex

A

Heterozygotes have differently shaped
melt curve (dip). Combination of mutant and wildtype

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

Southern blot

A
  • Digest DNA with restriction enzymes
  • Seperate DNA fragments by gel electrophoresis
  • Hybridise probe to complementary target sequence
  • Enzyme conjugated to probe produces luminescent product
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

RFLP

A
  • Restriction Fragment Length Polymorphism
  • Mutations can create or destroy restriction enzyme sites which are detected via southern blot.
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

Disadvantage of RFLP

A
  • Not all mutations will cause changes to create or destroy RE sites
  • Next gen sequencing has issues with repetitive sequences, RFLP can be used
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

Microarray

A

Fixed DNA sequences which hybridise with fragmented labelled target DNA. can look at many variants simultaneously

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

Steps of microarray

A
  • Oligonucleotide probes vary in sequence and immobilised on chip
  • DNA sample is labelled by fluorescent label
  • Fragmented DNA hybridises with immobilised probes
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

Applications of microarray

A
  • Comparative Genome Hybridisation
  • Expression array (mRNA –> cDNA, cDNA binds to chip, shows what is expressed)
  • SNP detection / mutation analysis
  • common pathogenic SNPs
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

Types of pathogenic variants

A
  • Single gene (mandelian) disease (mutation in one gene responsible for disease phenotype. CF, Sickle cell)
  • Multifactoral diseases (influenced by more than one gene, environmental causes, type 2 diabetes)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

WGS advantages

A

Don’t need to have target sequence, or even disease of interest to be able to identify mutant

17
Q

Ethical dilemmas of WGS

A
  • Not testing for a specific mutation or disease
  • Many revealed disorders will have no prevention or treatment (BRCA in infants)
  • Variants of Uncertain Significance (VUS)